ClinicalTrials.Veeva

Menu

FearLess in Cognitively Intact Patients With Glioma

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Completed

Conditions

Fear of Cancer
Glioma

Treatments

Behavioral: FearLess Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05604365
HM20025081 (Other Identifier)
MCC-22-19485

Details and patient eligibility

About

This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patient inclusion:

  • Confirmed glioma diagnosis (grade II-IV) via histopathology
  • Be a minimum of 2 weeks post surgical repair or biopsy (if applicable)
  • Elevated FCR [> 13 on Fear of Cancer Recurrence Inventory]
  • Primarily English speaking

Caregiver Inclusion:

  • Loved one, or non-paid care partner to a patient with a confirmed glioma diagnosis (grade II-IV) via histopathology
  • Elevated FCR [> 13 on Fear of Cancer Recurrence Inventory]
  • Primarily English speaking
  • Age 18+

Exclusion criteria

Patient:

  • Cognitive impairment [< or equal to 31 on the Telephone Interview for Cognitive Status (TICS)]
  • Inability to attend virtual sessions (e.g. due to lack of stable internet connection, difficulty using technology)
  • Inability to understand and provide informed consent.

Caregiver:

  • Inability to attend virtual sessions (e.g. due to lack of stable internet connection, difficulty using technology)
  • Inability to understand and provide informed consent.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

22 participants in 3 patient groups

Arm 1
Experimental group
Description:
Patients Only
Treatment:
Behavioral: FearLess Intervention
Arm 2
Experimental group
Description:
Patients and Caregivers
Treatment:
Behavioral: FearLess Intervention
Arm 3
Experimental group
Description:
Caregivers Only
Treatment:
Behavioral: FearLess Intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Autumn Lanoye, PhD; Ashlee Loughan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems